Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c. (2003). Swiss Medical Weekly, 133(3334), 455-460. https://doi.org/10.4414/smw.2003.10300